Pancrelipase treatment in a patient with the history of Roux-en-Y gastric bypass operation that developed resistant hypocalcemia secondary to total thyroidectomy

Open access

Abstract

Objective. Roux-en-Y gastric bypass (RYGB) is an independent risk factor for moderate hypocalcaemia and may lead to the development of resistant hypocalcaemia following thyroid surgery.

Subject and Results. A 35-year old female patient was referred to our hospital by her family physician for treatment of resistant hypocalcaemia. The patient underwent RYGB three years ago and a total thyroidectomy for a benign thyroid nodule one year ago. Calcitriol, calcium carbonate, magnesium oxide, and ergocalciferol therapeutic dosages were incremented. Despite dosage increments, the desired calcium levels were not achieved. In the sixth month after admission to our hospital, pancrelipase was added to patient’s treatment scheme. On the following visit, a good calcium increase had been achieved.

Conclusion. This report presents a case history of RYGB and resistant hypocalcaemia, which developed after thyroid surgery and positively responded to pancrelipase treatment.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • Alfonso B Jacobson AS Alon EE Via MA. Previous gastric bypass surgery complicating total thyroidectomy. Ear Nose Throat J 94 12–16 2015.

  • Bischof MG Heinze G Vierhapper H. Vitamin D status and its relation to age and body mass index. Horm Res 66 211–215 2006.

  • Bloomberg RD Fleishman A Nalle JE Herron DM Kini S. Nutritional deficiencies following bariatric surgery: What have we learned? Obes Surg 15 145–154 2005.

  • Carlin AM Rao DS Meslemani AM Genaw JA Parikh NJ Levy S Bhan A Talpos GB. Prevalence of vitamin D depletion among morbidly obese patients seeking gastric bypass surgery. Surg Obes Relat Dis 2 98–103 2006.

  • Delbridge L Guinea AI Reeve TS. Total thyroidectomy for bilateral benign multinodular goiter: effect of changing practice. Arch Surg 134 1389–1393 1999.

  • Durr ML Saunders JR Califano JA Tufano RP Koch WM Ha PK. Severe hypocalcemia complicating thyroid surgery after Roux-en-Y gastric bypass procedure. Arch Otolaryngol Head Neck Surg 135 507–510 2009.

  • Gross JA Olsen SM Koch CA Moore EJ. Severe symptomatic hypocalcemia following total thyroidectomy in a patient with a history of Roux-en-Y gastric bypass surgery. Ear Nose Throat J 93 6–11 2014.

  • Hundahl S Cady B Cunningham M Mazzaferri E McKee RF Rosai J Shah JP Fremgen AM Stewart AK Holzer S. Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the United States during 1996. Cancer 89 202–217 2000.

  • Johnson JM Maher JW DeMaria EJ Downs RW Wolfe LG Kellum JM. The long-term effects of gastric bypass on vitamin D metabolism. Ann Surg 243 701–704 2006.

  • Kohn GP Galanko JA Overby DW Farrell TM. Recent trends in bariatric surgery case volume in the United States. Surgery 146 375–380 2009.

  • Lo Menzo E Szomstein S Rosenthal RJ. Changing trends in bariatric surgery. Scand J Surg 104 18–23 2015.

  • McKenzie TJ Chen Y Hodin RA Shikora SA Hutter MM Gaz RD Moore FD Jr Lubitz CC. Recalcitrant hypocalcemia after thyroidectomy in patients with previous Roux-en-Y gastric bypass. Surgery 154 1300–1306 2013.

  • Mechanick JI Kushner RF Sugerman HJ Gonzalez-Campoy JM Collazo-Clavell ML Guven S Spitz AF Apovian CM Livingston EH Brolin R Sarwer DB Anderson WA Dixon J. American Association of Clinical Endocrinologists The Obesity Society and American Society for Metabolic & Bariatric Surgery Medical Guidelines for Clinical Practice for the perioperative nutritional metabolic and nonsurgical support of the bariatric surgery patient. Surg Obes Relat Dis 4 S109–S184 2008.

  • Miller AD Smith KM. Medication and nutrient administration considerations after bariatric surgery. Am J Health Syst Pharm 63 1852–1857 2006.

  • Nguyen NT Masoomi H Magno CP Nguyen XT Laugenour K Lane J. Trends in use of bariatric surgery 2003–2008. J Am Coll Surg 213 261–216 2011.

  • Panazzolo DG Braga TG Bergamim A Pires B Almeida H Kraemer-Aguiar LG. Hypoparathyroidism after Rouxen-Y gastric bypass--a challenge for clinical management: a case report. J Med Case Rep 8 357 2014.

  • Pietras SM Holick MF. Refractory hypocalcemia following near-total thyroidectomy in a patient with a prior Rouxen-Y gastric bypass. Obes Surg 19 524–526 2009.

  • Salinger EM Moore JT. Profound hypocalcemia after neartotal thyroidectomy in a roux-en-Y gastric bypass patient. Am Surg 76 7–8 2010.

  • Slater GH Ren CJ Siegel N Williams T Barr D Wolfe B Dolan K Fielding GA. Serum fat-soluble vitamin deficiency and abnormal calcium metabolism after malabsorptive bariatric surgery. J Gastrointest Surg 8 48–55 2004.

  • Testa A Fant V De Rosa A Fiore GF Grieco V Castaldi P Persiani R Rausei S D’ugo D De Rosa G. Calcitriol plus hydrochlorothiazide prevents transient post-thyroidectomy hypocalcemia. Horm Metab Res 38 821–826 2006.

  • Toh SY Zarshenas N Jorgensen J. Prevalence of nutrient deficiencies in bariatric patients. Nutrition 25 1150–1156 2009.

  • Tondapu P Provost D Adams-Huet B Sims T Chang C Sakhaee K. Comparison of the Absorption of calcium carbonate and calcium citrate after roux-en-Y gastric bypass. Obes Surg 19 1256–1261 2009.

  • Wortsman J Matsuoka LY Chen TC Lu Z Holick MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 72 690–693 2000.

Search
Journal information
Impact Factor


CiteScore 2018: 1.27

SCImago Journal Rank (SJR) 2018: 0.411
Source Normalized Impact per Paper (SNIP) 2018: 0.441

Cited By
Metrics
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 371 211 12
PDF Downloads 197 140 4